High triglyceride causes: Difference between revisions

Jump to navigation Jump to search
Line 18: Line 18:
{|style="width:80%; height:100px" border="1"
{|style="width:80%; height:100px" border="1"
|style="height:100px"; style="width:25%" border="1" bgcolor="LightSteelBlue" |'''Cardiovascular'''
|style="height:100px"; style="width:25%" border="1" bgcolor="LightSteelBlue" |'''Cardiovascular'''
|style="height:100px"; style="width:75%" border="1" bgcolor="Beige" | No underlying causes
|style="height:100px"; style="width:75%" border="1" bgcolor="Beige" | [[Alström syndrome]], [[apolipoprotein E|apoprotein E deficiency]], [[high chylomicron|chylomicron levels raised (plasma)]], [[familial chylomicronemia]], [[familial combined hyperlipidemia]], [[familial hypertriglyceridemia]], [[hyperlipoproteinemia type V|hyperlipoproteinemia, familial type 5]], [[IDL|intermediate density lipoprotein levels raised (plasma or serum)]]
|-
|-
|bgcolor="LightSteelBlue"| '''Chemical/Poisoning'''
|bgcolor="LightSteelBlue"| '''Chemical/Poisoning'''
Line 29: Line 29:
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Dermatologic'''
| '''Dermatologic'''
|bgcolor="Beige"| No underlying causes
|bgcolor="Beige"| [[Systemic  lupus erythematosus]]
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Drug Side Effect'''
| '''Drug Side Effect'''
|bgcolor="Beige"| No underlying causes
|bgcolor="Beige"| [[Amprenavir]], [[atazanavir|atazanavir sulfate]], [[atypical  antipsychotics]], [[bendrofluazide]], [[beta-blockers]], [[bexarotene]], [[chlorthalidone]], [[clomiphene]], [[colesevelam|colesevelam hydrochloride]], [[colestyramine]], [[combined oral contraceptive  pill]], [[desvenlafaxine]], [[diuretics]], [[estrogen replacement  therapy]], [[fosamprenavir]], [[glucocorticoids]], [[hydrochlorothiazide]], [[interferon alpha]], [[linagliptin]], [[lopinavir]], [[mirtazapine]], [[non-nucleoside reverse  transcriptase inhibitors]], [[olanzapine]], [[isotretinoin|oral isotretinoin]], [[propofol]], [[protease inhibitors]], [[ritonavir]], [[saquinavir]], [[tamoxifen]], [[temsirolimus]], [[tipranavir]], [[tocilizumab]]
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
Line 41: Line 41:
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Endocrine'''
| '''Endocrine'''
|bgcolor="Beige"| No underlying causes
|bgcolor="Beige"| [[Cushing's syndrome]], [[diabetes mellitus]], [[hypothyroidism]], [[insulin resistance]], [[metabolic syndrome]], [[polycystic ovary  syndrome]], [[reaven syndrome|Reaven syndrome X]]
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
Line 49: Line 49:
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Gastroenterologic'''
| '''Gastroenterologic'''
|bgcolor="Beige"| No underlying causes
|bgcolor="Beige"|[[Acute pancreatitis]], [[Alagille syndrome]], [[carnitine palmitoyltransferase 1 deficiency]], [[cholesteryl ester storage  disease]], [[glycogen storage disease|glycogen storage disease type 1]], [[glycogenosis type 1a]], [[liver cirrhosis]], [[non-alcoholic fatty liver  disease]]
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Genetic'''
| '''Genetic'''
|bgcolor="Beige"| No underlying causes
|bgcolor="Beige"| [[Alagille  syndrome]], [[Alström syndrome]], [[apolipoprotein E|apoprotein E deficiency]], [[carnitine palmitoyltransferase 1 deficiency]], [[cholesteryl ester storage disease]], [[congenital generalized  lipodystrophy|congenital generalized  lipodystrophy type 1]], [[apolipoprotein C2|deficiency of apolipoprotein C2 ]], [[familial chylomicronemia]], [[familial combined  hyperlipidemia]], [[familial histiocytic  reticulosis]], [[familial hypertriglyceridemia]], [[fish eye disease]], [[glycogen storage disease|Glycogen storage disease type 1]], [[glycogenosis type 1a]], [[hyperlipoproteinemia type V|hyperlipoproteinemia, familial type 5]], [[lecithin cholesterol  acyltransferase deficiency]], [[metabolic syndrome]], [[Niemann-Pick disease|Niemann-Pick disease type  B]], [[reaven syndrome|Reaven syndrome X]], [[sphingomyelinase  deficiency]], [[Tangier disease]]
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Hematologic'''
| '''Hematologic'''
|bgcolor="Beige"| No underlying causes
|bgcolor="Beige"| [[Familial  histiocytic reticulosis]]
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Iatrogenic'''
| '''Iatrogenic'''
|bgcolor="Beige"| No underlying causes
|bgcolor="Beige"| [[Parenteral  nutrition]]
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
Line 69: Line 69:
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Musculoskeletal/Orthopedic'''
| '''Musculoskeletal/Orthopedic'''
|bgcolor="Beige"| No underlying causes
|bgcolor="Beige"| [[Systemic lupus erythematosus]]
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Neurologic'''
| '''Neurologic'''
|bgcolor="Beige"| No underlying causes
|bgcolor="Beige"| [[Niemann-Pick disease|Niemann-Pick disease type B]], [[sphingomyelinase  deficiency]]
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Nutritional/Metabolic'''
| '''Nutritional/Metabolic'''
|bgcolor="Beige"| No underlying causes
|bgcolor="Beige"|  
 
[[Alcohol]],
 
[[Apoprotein E  deficiency]],
 
[[Chylomicron levels raised  (plasma)]],
 
[[Deficiency of apolipoprotein  C2 ]],
 
[[Familial  chylomicronemia]],
 
[[Familial combined  hyperlipidemia]],
 
[[Familial  hypertriglyceridemia]],
 
[[Glycogen storage disease  type 1]],
 
[[Glycogenosis type 1a]],
 
[[High carbohydrate or high  glycemic index]],
 
[[Hyperlipoproteinemia,  familial type 5]],
 
[[Intermediate density  lipoprotein levels raised (plasma or serum)]],
 
[[Lipodystrophy]],
 
[[Lipoprotein lipase  deficiency]],
 
[[Obesity]],
 
[[Tangier disease]],
 
[[Very low density lipoprotein  levels raised (plasma or serum)]],
 
[[Vitamin E deficiency,  familial isolated]],
 
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Obstetric/Gynecologic'''
| '''Obstetric/Gynecologic'''
|bgcolor="Beige"| No underlying causes
|bgcolor="Beige"|  
[[Polycystic  ovary syndrome]],
 
[[Pregnancy]],
 
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
Line 89: Line 130:
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Ophthalmologic'''
| '''Ophthalmologic'''
|bgcolor="Beige"| No underlying causes
|bgcolor="Beige"|  
[[Diabetes  mellitus]],
 
[[Lecithin cholesterol  acyltransferase deficiency]],
 
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Overdose/Toxicity'''
| '''Overdose/Toxicity'''
|bgcolor="Beige"| No underlying causes
|bgcolor="Beige"|  
[[Alcohol]],
 
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
Line 105: Line 152:
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Renal/Electrolyte'''
| '''Renal/Electrolyte'''
|bgcolor="Beige"| No underlying causes
|bgcolor="Beige"|  
[[Chronic  kidney disease]],
 
[[Chronic renal  insufficiency]],
 
[[Diabetes mellitus]],
 
[[Nephrotic syndrome]],
 
[[Systemic lupus  erythematosus]],
 
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Rheumatology/Immunology/Allergy'''
| '''Rheumatology/Immunology/Allergy'''
|bgcolor="Beige"| No underlying causes
|bgcolor="Beige"|  
[[Macrophage  activation syndrome]],
 
[[Metabolic syndrome]],
 
[[Paraproteinemias]],
 
[[Reaven syndrome X]],
 
[[Systemic lupus  erythematosus]],
 
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
Line 125: Line 192:
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Miscellaneous'''
| '''Miscellaneous'''
|bgcolor="Beige"| No underlying causes
|bgcolor="Beige"|  
[[Alcohol]],
 
|-
|-
|}
|}

Revision as of 16:11, 25 September 2013

Triglyceride Microchapters

Home

Patient information

Overview

Historical Perspective

Classification

Biochemistry

Physiology

Clinical Correlation

Triglyceride Laboratory Test

High Triglyceride

Epidemiology and Demographics
Pathophysiology
Causes
Prognosis and Complications
History and Symptoms
Physical Examination

Low Triglyceride

Epidemiology and Demographics
Pathophysiology
Causes
Prognosis and Complications

Treatment

Lifestyle modification

Medical Therapy

Primary Prevention

Secondary Prevention

Landmark Trials

Future or Investigational Therapies

Case Studies

Case #1

High triglyceride causes On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of High triglyceride causes

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on High triglyceride causes

CDC on High triglyceride causes

High triglyceride causes in the news

Blogs on High triglyceride causes

Directions to Hospitals Treating Triglyceride

Risk calculators and risk factors for High triglyceride causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Priyamvada Singh, M.B.B.S. [2]

Overview

Hypertriglyceridemia can occur due to various causes, including genetics, familial, metabolic and drugs

Causes

Life Threatening Causes

Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated.

Common Causes

Causes by Organ System

Cardiovascular Alström syndrome, apoprotein E deficiency, chylomicron levels raised (plasma), familial chylomicronemia, familial combined hyperlipidemia, familial hypertriglyceridemia, hyperlipoproteinemia, familial type 5, intermediate density lipoprotein levels raised (plasma or serum)
Chemical/Poisoning No underlying causes
Dental No underlying causes
Dermatologic Systemic lupus erythematosus
Drug Side Effect Amprenavir, atazanavir sulfate, atypical antipsychotics, bendrofluazide, beta-blockers, bexarotene, chlorthalidone, clomiphene, colesevelam hydrochloride, colestyramine, combined oral contraceptive pill, desvenlafaxine, diuretics, estrogen replacement therapy, fosamprenavir, glucocorticoids, hydrochlorothiazide, interferon alpha, linagliptin, lopinavir, mirtazapine, non-nucleoside reverse transcriptase inhibitors, olanzapine, oral isotretinoin, propofol, protease inhibitors, ritonavir, saquinavir, tamoxifen, temsirolimus, tipranavir, tocilizumab
Ear Nose Throat No underlying causes
Endocrine Cushing's syndrome, diabetes mellitus, hypothyroidism, insulin resistance, metabolic syndrome, polycystic ovary syndrome, Reaven syndrome X
Environmental No underlying causes
Gastroenterologic Acute pancreatitis, Alagille syndrome, carnitine palmitoyltransferase 1 deficiency, cholesteryl ester storage disease, glycogen storage disease type 1, glycogenosis type 1a, liver cirrhosis, non-alcoholic fatty liver disease
Genetic Alagille syndrome, Alström syndrome, apoprotein E deficiency, carnitine palmitoyltransferase 1 deficiency, cholesteryl ester storage disease, congenital generalized lipodystrophy type 1, deficiency of apolipoprotein C2 , familial chylomicronemia, familial combined hyperlipidemia, familial histiocytic reticulosis, familial hypertriglyceridemia, fish eye disease, Glycogen storage disease type 1, glycogenosis type 1a, hyperlipoproteinemia, familial type 5, lecithin cholesterol acyltransferase deficiency, metabolic syndrome, Niemann-Pick disease type B, Reaven syndrome X, sphingomyelinase deficiency, Tangier disease
Hematologic Familial histiocytic reticulosis
Iatrogenic Parenteral nutrition
Infectious Disease No underlying causes
Musculoskeletal/Orthopedic Systemic lupus erythematosus
Neurologic Niemann-Pick disease type B, sphingomyelinase deficiency
Nutritional/Metabolic

Alcohol,

Apoprotein E deficiency,

Chylomicron levels raised (plasma),

Deficiency of apolipoprotein C2 ,

Familial chylomicronemia,

Familial combined hyperlipidemia,

Familial hypertriglyceridemia,

Glycogen storage disease type 1,

Glycogenosis type 1a,

High carbohydrate or high glycemic index,

Hyperlipoproteinemia, familial type 5,

Intermediate density lipoprotein levels raised (plasma or serum),

Lipodystrophy,

Lipoprotein lipase deficiency,

Obesity,

Tangier disease,

Very low density lipoprotein levels raised (plasma or serum),

Vitamin E deficiency, familial isolated,

Obstetric/Gynecologic

Polycystic ovary syndrome,

Pregnancy,

Oncologic No underlying causes
Ophthalmologic

Diabetes mellitus,

Lecithin cholesterol acyltransferase deficiency,

Overdose/Toxicity

Alcohol,

Psychiatric No underlying causes
Pulmonary No underlying causes
Renal/Electrolyte

Chronic kidney disease,

Chronic renal insufficiency,

Diabetes mellitus,

Nephrotic syndrome,

Systemic lupus erythematosus,

Rheumatology/Immunology/Allergy

Macrophage activation syndrome,

Metabolic syndrome,

Paraproteinemias,

Reaven syndrome X,

Systemic lupus erythematosus,

Sexual No underlying causes
Trauma No underlying causes
Urologic No underlying causes
Miscellaneous

Alcohol,

Causes in Alphabetical Order


References

  1. 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 1.11 1.12 1.13 Kolovou GD, Anagnostopoulou KK, Kostakou PM, Bilianou H, Mikhailidis DP (2009). "Primary and secondary hypertriglyceridaemia". Curr Drug Targets. 10 (4): 336–43. PMID 19355858.
  2. Fallat RW, Glueck CJ (1976). "Familial and acquired type V hyperlipoproteinemia". Atherosclerosis. 23 (1): 41–62. PMID 1078394.

Template:WikiDoc Sources